MARKET

CHMA

CHMA

Chiasma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.630
-0.120
-2.53%
After Hours: 4.630 0 0.00% 16:00 01/24 EST
OPEN
4.760
PREV CLOSE
4.750
HIGH
4.800
LOW
4.560
VOLUME
204.75K
TURNOVER
--
52 WEEK HIGH
9.25
52 WEEK LOW
3.300
MARKET CAP
194.54M
P/E (TTM)
-4.0768
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CHMA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CHMA News

  • Does Chiasma, Inc. (NASDAQ:CHMA) Have A High Beta?
  • Simply Wall St..5h ago
  • Chiasma Announces FDA Acceptance Of MYCAPSSA New Drug Application Resubmission
  • Benzinga.01/13 12:29
  • Chiasma Announces FDA Acceptance of MYCAPSSA® New Drug Application Resubmission
  • GlobeNewswire.01/13 12:00
  • Chiasma refiles Mycapssa application in U.S.; shares up 4% premarket
  • Seeking Alpha - Article.01/10 14:15

More

Industry

Pharmaceuticals
-1.84%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About CHMA

Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial of its TPE platform-based product candidate, oral octreotide capsules (trade named as MYCAPSSA) for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Octreotide is an analog of somatostatin, a natural inhibitor of growth hormone secretion. The Company is developing octreotide capsules as a liquid-filled solid gelatin capsule formulation, which is intended to be taken over twice a day. The Company's TPE technology enhances the absorption through the intestinal wall of drugs. The Company also focuses on developing CH2 for Orphan indication.
More

Webull offers Chiasma Inc (CHMA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.